Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» head and neck cancer
head and neck cancer
FDA gives OK, Cel-Sci clinical hold finally lifted
BioPharma Dive
Tue, 08/15/17 - 09:29 am
FDA
Cell-Sci
Multikine
clinical trials
head and neck cancer
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer
Xconomy
Tue, 07/25/17 - 12:06 am
Merck
Keytruda
head and neck cancer
Bristol-Myers' Opdivo racks up latest NICE rejection, this time in head and neck cancer
Fierce Pharma
Wed, 04/12/17 - 06:07 pm
Bristol-Myers Squibb
Opdivo
NICE
head and neck cancer
Bristol's Bid To Get Ahead In Head And Neck
Seeking Alpha
Tue, 11/15/16 - 09:17 am
Bristol-Myers Squibb
head and neck cancer
Opdivo
Keytruda
Merck
FDA slaps a partial hold on one of AstraZeneca’s crucial durvalumab programs
Endpoints
Fri, 10/28/16 - 10:12 am
FDA
AstraZeneca
durvalumab
clinical trials
head and neck cancer
How Pfizer Plans to Extend Ibrance beyond Breast Cancer Treatment
Market Realist
Fri, 09/2/16 - 11:24 am
Pfizer
Ibrance
breast cancer
head and neck cancer
lung cancer
pancreatic cancer
Bristol-Myers's Opdivo Extends Survival in Head, Neck Cancer
Bloomberg
Tue, 04/19/16 - 06:14 pm
Bristol-Myers Squibb
Opdivo
head and neck cancer
Keytruda, Opdivo near new cancer uses where they won't butt heads
Fierce Pharma
Fri, 04/15/16 - 08:39 am
Keytruda
Opdivo
Bristol-Myers Squibb
Merck
Hodgkin's lymphoma
head and neck cancer
Cel-Sci's Enrollment Math Doesn't Add up
TheStreet.com
Fri, 08/1/14 - 11:40 am
head and neck cancer
Cel-Sci
Multikine
First Presentation of Early Data for Pembrolizumab (MK-3475), Merck’s Investigational Anti-PD-1 Antibody, in Advanced Head and Neck Cancer at ASCO 2014
Yahoo/BusinessWire
Sun, 06/1/14 - 12:18 pm
Pembrolizumab
Merck
head and neck cancer
Oncolytics Biotech reports tumor stabilization or shrinkage in REOLYSIN study
The Fly on the Wall
Tue, 04/8/14 - 08:11 am
Oncolytics
Reolysin
head and neck cancer
Cel-Sci's Multikine - Potential 21st Century Superdrug
Seeking Alpha
Fri, 03/14/14 - 08:40 am
Cel-Sci
head and neck cancer
Multikine
ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers
Seeking Alpha
Sun, 04/14/13 - 12:16 pm
non-small cell lung cancer
Immunogen
IMGN289
head and neck cancer
Pilot Study in Patients with Head and Neck Cancer Finds That Derma Sciences’ MEDIHONEY® Reduces Hospital Stays in the U.K.
Thu, 09/20/12 - 10:43 pm
research
patient
head and neck cancer
Derma Sciences
Medihoney
UK
Oncolytics expands enrollment for cancer drug late-stage trial
Reuters
Thu, 09/13/12 - 09:49 am
head and neck cancer
Oncolytics
Reolysin
Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug
Seeking Alpha
Tue, 03/13/12 - 11:25 am
Cel-Sci
Teva Pharmaceuticals
Multikine
head and neck cancer
SciClone Pharmaceuticals halts mid-stage study of potential drug due to poor results
Yahoo/AP
Fri, 03/2/12 - 09:49 am
SciClone
head and neck cancer
SCV-07
oral mucositis
CEL-SCI says Multikine Phase III trial launched in dozens of hospitals
The Fly on the Wall
Mon, 01/23/12 - 11:25 am
Cel-Sci
Multikine
head and neck cancer
CEL-SCI Corporation Releases Letter to Shareholders
Yahoo/BusinessWire
Sat, 01/21/12 - 01:08 pm
Cel-Sci
Multikine
head and neck cancer
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Bloomberg
Mon, 11/7/11 - 09:15 pm
Erbitux
Bristol-Myers Squibb
ImClone
Eli Lilly
head and neck cancer
Pages
« first
‹ previous
1
2
3
4
next ›
last »